SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001437749-17-004197
Filing Date
2017-03-10
Accepted
2017-03-10 07:11:31
Documents
5
Period of Report
2017-03-09
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K acrx20170309_8k.htm 8-K 28251
2 EXHIBIT 10.1 ex10-1.htm EX-10.1 875953
3 EXHIBIT 10.2 ex10-2.htm EX-10.2 23795
4 a2.jpg GRAPHIC 332948
5 a1.jpg GRAPHIC 311510
  Complete submission text file 0001437749-17-004197.txt   1816580
Mailing Address 351 GALVESTON DRIVE REDWOOD CITY CA 94063
Business Address 351 GALVESTON DRIVE REDWOOD CITY CA 94063 650-216-3500
ACELRX PHARMACEUTICALS INC (Filer) CIK: 0001427925 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35068 | Film No.: 17680110
SIC: 2834 Pharmaceutical Preparations